Doxorubicin is a widely used and promising anticancer drug; however, a severe dose-
dependent cardiotoxicity hampers its therapeutic value. Doxorubicin may cause acute and …

Despite the advent of new therapies and improved outcomes in patients with pulmonary
arterial hypertension (PAH), it remains a life-shortening disease and the time to diagnosis …

Background: Both BNP (B-type natriuretic peptide) and NT-proBNP (N-terminal pro B-type
natriuretic peptide) are widely used to aid diagnosis, assess the effect of therapy, and predict …

In the context of the high risk of heart failure (HF), rapid assessment of biomarker levels in
patients appears to be a quick and accurate approach to diagnosis and timely treatment …

Background The clinical use of common cardiac biomarkers, such as brain natriuretic
peptides and troponins, has traditionally been limited to adult populations in the assessment …

Data regarding the prognostic value of cardiac biomarkers in patients suffering from sepsis
or septic shock is scarce. Studies investigating the prognostic role of cardiac biomarkers in …

Assessment of patients' volume status at the bedside is a very important clinical skill that
physicians need in many clinical scenarios. Hypovolemia with hypotension and tissue under …

Chronic heart failure (CHF) is the leading cause of death worldwide. The regulatory
interactions of long non‑coding RNA (lncRNAs) and microRNAs (miRs) have important roles …

Accumulating evidence suggests that supplementation of n-3 PUFA was associated with
reduction in risk of major cardiovascular events. This meta-analysis was to systematically …

Early detection and risk stratification of patients with heart failure (HF) are crucial to improve
outcomes. Given the complexity of the pathophysiological processes of HF and the …